I agree that would mean they are excited. Just surprised that such excitement doesn’t translate to bringing big investors on board at higher valuations rather than diluting the shareholders at 60-70 cents? I’d expect they’d shout from the rooftop as they did with specials certification last year, commercial manufacturing application, and PIP approvals this summer!
Why aren’t they hiring/building a commercial team if they were close to MHRA approvals? One of these 2 reasons make the most sense: 1) they are far off from reimbursement approvals or 2) they have a big partner lined up ready to go at MHRA/reimbursement approval.
If it turns out to be number 1 then don’t you agree they have been stringing retail along by their ambiguous statements and selective quiet period over the years?
Market Data 
Markets 
AI
